https://oncbrain.oncologytoolkit.com/ AI-summarized oncology meeting studies, curated by a subspecialist. One item per study. en Sat, 30 May 2026 00:00:00 GMT https://oncbrain.oncologytoolkit.com/2026-05-30/#spin-celiac-srs https://oncbrain.oncologytoolkit.com/2026-05-30/#spin-celiac-srs Sat, 30 May 2026 00:00:00 GMT supportive [Caveats dominate] 89% pain response in SPIN-2 pts (baseline pain >6 + no prior neurotoxic chemo) vs 32% SPIN-0 after celiac SRS. Eligible: Pancreatic cancer, intractable retroperitoneal pain, planned celiac plexus SRS